BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22430509)

  • 1. The chemokine receptor CXCR3 limits injury after acute toxic liver damage.
    Zaldivar MM; Berres ML; Sahin H; Nellen A; Heinrichs D; Schmitz P; Gassler N; Streetz KL; Trautwein C; Wasmuth HE
    Lab Invest; 2012 May; 92(5):724-34. PubMed ID: 22430509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
    Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
    Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
    Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
    J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
    Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
    Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.
    Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW
    BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.
    Ajuebor MN; Wondimu Z; Hogaboam CM; Le T; Proudfoot AE; Swain MG
    Am J Pathol; 2007 Jun; 170(6):1975-88. PubMed ID: 17525265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.
    Berres ML; Trautwein C; Zaldivar MM; Schmitz P; Pauels K; Lira SA; Tacke F; Wasmuth HE
    Biol Chem; 2009 Oct; 390(10):1039-45. PubMed ID: 19642876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
    Yano T; Ohira M; Nakano R; Tanaka Y; Ohdan H
    PLoS One; 2017; 12(10):e0186997. PubMed ID: 29088306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
    Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
    Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation.
    Gauthier M; Kale SL; Oriss TB; Scholl K; Das S; Yuan H; Hu S; Chen J; Camiolo M; Ray P; Wenzel S; Ray A
    J Allergy Clin Immunol; 2022 Jan; 149(1):113-124.e7. PubMed ID: 34146578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development.
    Filtjens J; Foquet L; Taveirne S; Van Ammel E; Vanhees M; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van den Steen PE; Leclercq G
    PLoS One; 2014; 9(1):e87463. PubMed ID: 24498110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant natural killer T-cell-deficient mice display increased CCl₄ -induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration.
    Lisbonne M; L'Helgoualc'h A; Nauwelaers G; Turlin B; Lucas C; Herbelin A; Piquet-Pellorce C; Samson M
    Eur J Immunol; 2011 Jun; 41(6):1720-32. PubMed ID: 21469102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the TNF and FasL produced by CD11b Kupffer cells/macrophages in CCl4-induced acute hepatic injury.
    Sato A; Nakashima H; Nakashima M; Ikarashi M; Nishiyama K; Kinoshita M; Seki S
    PLoS One; 2014; 9(3):e92515. PubMed ID: 24667392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition.
    Singh UP; Singh S; Singh R; Cong Y; Taub DD; Lillard JW
    J Interferon Cytokine Res; 2008 Jan; 28(1):31-43. PubMed ID: 18370870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.
    Fadel SA; Bromley SK; Medoff BD; Luster AD
    Eur J Immunol; 2008 Dec; 38(12):3376-87. PubMed ID: 19039768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.